Preferences of evidence summary users’ | N (%) | |
Sources most familiar with to access evidence summariesa | Cochrane | 8 (66.6) |
Evidence Aid | 7 (58.3) | |
Relief Web | 7 (58.3) | |
Campbell Collaboration | 4 (33.3) | |
International Initiative for Impact Evaluation (3ie) | 4 (33.3) | |
Victoria’s Hub for Health Services and Business (health.vic.gov.au) | 2 (16.6) | |
Africa Center for Evidence (University of Johannesburg) | 0 (0) | |
Other | 0 (0) | |
Frequency of referring to evidence summaries during the COVID-19 pandemica | Very frequently (more than 7 times) | 3 (25) |
Frequently (4 to 6 times) | 2 (16.6) | |
Occasionally (2 to 4 times) | 7 (58.3) | |
Rarely (less than 2 times) | 0 (0) | |
Extent information in the evidence summaries influenced final decisions | To a great extent | 3 (25) |
Somewhat | 9 (75) | |
Very little | 0 (0) | |
Not at all | 0 (0) | |
Challenges with finding and using research evidence in crisesb | Websites require moving through several webpages to reach the desired information | 6 (50) |
Lack of evidence relating to specific crisis areas | 4 (33.3) | |
Lack of evidence relating to my field of work | 2 (16.6) | |
Some websites’ interface is not user-friendly | 1 (8.3) | |
Other | 2 (16.6) | |
Features would like to see within an evidence summary (if they were to use them)a | Concise summary of the evidence, including benefits, harms and costs, and implementation considerations and recommendations | 11 (78.5) |
Key messages in bullet point format | 9 (64.2) | |
Information about the research methods of the summarized systematic review | 8 (57.1) | |
Assessment of the quality of the evidence | 8 (57.1) | |
Infographics | 0 (0) | |
Indirectness assessment | 3 (21.4) | |
Date of search strategy (how up to date is the evidence) | 7 (50) | |
A link that directs you to the full text source | 13 (92.8) | |
Full text pdf option | 6 (42.8) | |
Full-text Citations | 3 (21.4) | |
Other | 2 (14.2) | |
Concise summary of the evidence, including benefits, harms and costs, and implementation considerations and recommendations | 0 (0) | |
Preferences of non-evidence summary users’ | N (%) | |
Reasons for not using Evidence Summaries Websites | No specific reason | 4 (28.5) |
Never heard of them before | 3 (21.4) | |
I do not usually need such tools for my work | 1 (7.1) | |
I find such kind of evidence as “very little informing” | 0 (0) | |
I prefer reading the in-depth evidence for a clearer picture | 2 (14.2) | |
Other | 4 (28.5) | |
Features to help them decide which evidence summary website to choose | Based on credibility of website | 9 (64.2) |
Based on the number of years of website’s activity | 1 (7.1) | |
Would rely on a colleague’s previous experience | 3 (21.4) | |
Other | 1 (7.1) | |
Extent they anticipate evidence summaries will have influence on their future decision making | To a great extent | 4 (28.5) |
To a moderate extent | 8 (57.1) | |
To a small extent | 2 (14.2) | |
Not at all | 0 (0) | |
Anticipate using evidence summaries in the future | Yes | 9 (64.2) |
Maybe | 5 (35.7) | |
No | 0 (0) | |
Features would like to see within an evidence summary (if they were to use them)a | Concise summary of the evidence | 11 (78.5) |
Information about the research methods of the summarized research paper | 9 (64.2) | |
Assessment of the quality of the evidence | 8 (57.1) | |
Infographics | 8 (57.1) | |
Risk of bias assessment | 0 (0) | |
Indirectness assessment | 3 (21.4) | |
Date of search strategy | 7 (50) | |
A link that directs you to the full text source | 13 (92.8) | |
Full text pdf option | 6 (42.8) | |
Implication’s considerations including contextual factors | 3 (21.4) | |
Equity related considerations | 2 (14.2) | |
Other | 0 (0) |